More importantly this show that Europe look at CE Mark (which was a major concern) to use the medical device, there's no doubt the 1st US clinical trial was stuff up by management but the 2nd US clinical trial were 33% of the time the 2 respiratory doctors at one of the most prodigious hospital couldn't even agree indicate how subjective respiratory disease diagnosis will always be if ResAppDx isn't used.
RAP tech on Ch 7 Sydney?, page-43
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)